Alumis (ALMS) Equity Ratio (2023 - 2025)
Alumis (ALMS) reported Equity Ratio of 0.73 for Q4 2025, down 4.11% year-over-year from 0.76 in Q4 2024, and down 7.23% quarter-over-quarter from 0.79 in Q3 2025.
Alumis (ALMS) Equity Ratio (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Equity Ratio data on file, last reported at 0.73 in Q4 2025.
- Equity Ratio for Q4 2025 came in at 0.73, down 4.11% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.73 (down 4.11% YoY), and the FY2025 annual result was 0.73, down 4.11% from the prior year.
- Equity Ratio fell to 0.73 in Q4 2025 per ALMS's latest filing, from 0.79 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.84 in Q3 2024 and troughed at 3.79 in Q4 2023.
- A 3-year average of 0.11 and a median of 0.75 in 2024 frame the typical range for Equity Ratio.
- On a YoY basis, Equity Ratio climbed as much as 148.01% in 2025 and fell as far as 6.63% in 2025.
- A 3-year view of Equity Ratio shows it stood at 3.79 in 2023, then jumped by 120.15% to 0.76 in 2024, then declined by 4.11% to 0.73 in 2025.
- Business Quant data shows ALMS's Equity Ratio at 0.73 in Q4 2025, 0.79 in Q3 2025, and 0.79 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 191.07 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 0.04 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.42 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 0.79 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.79 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.76 |
| Sep 30, 2024 | 0.84 |
| Jun 30, 2024 | -1.65 |
| Dec 31, 2023 | -3.79 |